Genome Institute of Singapore Buys Three Sequenom MassArrays | GenomeWeb
NEW YORK (GenomeWeb News) — The Genome Institute of Singapore has purchased two of Sequenom’s MassArray systems and will use them with the company’s iPLEX Gold genotyping assay, Sequenom said today.
 
The institute also will use Sequenom’s EpiTYPER epigenetic assay, used to study DNA methylation for cancer research.
 
GIS senior investigator Edison Liu said the institute will use the tools in its studies of population genetics, fine mapping analysis, and breast cancer. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.